Over his 40-year career in the medical device industry, Mr. Blankenship has served as a Director, CEO, President, COO and CTO of multiple start-up companies, as well as a product development executive for divisions of Eli Lilly, Pfizer and the Battelle Memorial Institute.
Mr. Blankenship has led business planning, staffing, funding, design, development, approval, manufacturing, launch and exits via acquisition. He is a medical device development specialist, including conception, design, qualification, production, and FDA and EU product approvals. He has served as a founding member of the Colorado Blackstone Entrepreneurs Network, a Director of the Colorado Bioscience Association (CBSA), and founding chair of the constituency committee for the Bioengineering program at the University of Colorado, Anschutz Medical Campus.
Mr. Blankenship is constantly seeking opportunities to bring meaningful healthcare and wellness services and products to the patients and caregivers who need them.
Mr. Blankenship is a graduate of the College of Engineering at Arizona State University, holds numerous US and foreign patents, and is a decorated veteran of the United States Submarine Service.